ABSTRACT
The airway surfaces are one of the most common ways of entry of infectious agents. The impact of upper respiratory tract diseases on salivary IgA production has not been fully understood. Therefore, in this study, we investigated the salivary IgA levels in patients suffered from upper respiratory tract diseases to indicate the effect of these diseases on salivary IgA production. In this study, salivary IgA level of 156 patients with inflammatory diseases of the upper respiratory tract including chronic rhinosinusitis, ear and pharynx diseases have been evaluated by direct immunoenzymatic determination. In pharynx disorders 11.8% of patients were IgA deficient, 76.2% were normal and11.8% had elevated level of IgA .In patients with chronic rhinosinusitis IgA deficiency was observed in 9.2%, 75.9% were normal and there was an elevation in 14.8% of patients .In ear disorders 11.6% were IgA deficient ,76.7% normal and 11.6% had elevated IgA level. This study provided evidence for the first time that changes in salivary IgA level are almost the same in different sites of infectious and inflammatory diseases of upper respiratory tract. Our investigation revealed that local up regulation of salivary IgA is not particular interest in majority of patients with upper respiratory tract infections